Descrizione Clinica
Apromised
Description
Food for special medical purposes.
Indicated for the dietary management of chronic kidney failure (IRC). Indicated for the dietary management of phenylchetonuria. Indicated for the dietary management of Parkinson's disease (in Levodopa therapy). The product, for its composition, is suitable for all three categories of patients.
In particular: the product has been specially formulated with reduced protein content, sodium, phosphorus and potassium ingredients to meet the nutritional needs of patients suffering from chronic kidney failure; the composition of the product has, in addition, a reduced contribution of phenylalanine for the dietary management of the subjects under conditions of Fenilchetonuria. Moreover, the product, thanks to a limited protein content, is also suitable for the dietary management of patients suffering from Parkinson's disease in treatment with Levodopa, as it does not interfere in the absorption of this amino acid. For the patient in Levodopa therapy, the degree of disfaction and possible malnutrition problems must be assessed due to defects that may arise under protein restriction.
Ingredients
Albicocca 36% (glucose syrup, apricot puree 25%, sucrose; thickener: pectin; acidifier: citric acid; preservative: potassium sorbate; aromas), starch wheat swallowed, sugar, fats and vegetable oils (carithè butter, sunflower oil), corn starch, rice flour, yolk'egg, caramelized sugar; thickeners: xanthan gum, carob seed flour; vegetable fibres (inulin, beet), aromas.
May contain lupine, milk, nuts, soybean.
Nutritional characteristics
Warnings
The product must be used under medical control and cannot be used as the only source of nutrition.
Conservation
Store in a cool and dry place away from heat sources and sunlight.
Integro packaging validation: four months.
Format
200 g (4 x 50 g).
Cod. DA07
Food for special medical purposes.
Indicated for the dietary management of chronic kidney failure (IRC). Indicated for the dietary management of phenylchetonuria. Indicated for the dietary management of Parkinson's disease (in Levodopa therapy). The product, for its composition, is suitable for all three categories of patients.
In particular: the product has been specially formulated with reduced protein content, sodium, phosphorus and potassium ingredients to meet the nutritional needs of patients suffering from chronic kidney failure; the composition of the product has, in addition, a reduced contribution of phenylalanine for the dietary management of the subjects under conditions of Fenilchetonuria. Moreover, the product, thanks to a limited protein content, is also suitable for the dietary management of patients suffering from Parkinson's disease in treatment with Levodopa, as it does not interfere in the absorption of this amino acid. For the patient in Levodopa therapy, the degree of disfaction and possible malnutrition problems must be assessed due to defects that may arise under protein restriction.
Ingredients
Albicocca 36% (glucose syrup, apricot puree 25%, sucrose; thickener: pectin; acidifier: citric acid; preservative: potassium sorbate; aromas), starch wheat swallowed, sugar, fats and vegetable oils (carithè butter, sunflower oil), corn starch, rice flour, yolk'egg, caramelized sugar; thickeners: xanthan gum, carob seed flour; vegetable fibres (inulin, beet), aromas.
May contain lupine, milk, nuts, soybean.
Nutritional characteristics
| Average values | for 100 g |
| Energy | 1.641 kJ/389 kcal |
| Fats of which saturated fatty acids | 9.6 g 1.6 g |
| Carbohydrate of which sugar | 74 g 37 g |
| Fibre | 0,8 g |
| Protein of which phenylalanine | 0,8 g 33 mg |
| Rooms of which iodine | 0.07 g 32 mg |
| Phosphorus | 37 mg |
| Potassium | 55 mg |
Warnings
The product must be used under medical control and cannot be used as the only source of nutrition.
Conservation
Store in a cool and dry place away from heat sources and sunlight.
Integro packaging validation: four months.
Format
200 g (4 x 50 g).
Cod. DA07
